Does ticlopidine reduce reocclusion and other adverse events after successful balloon angioplasty of occluded coronary arteries? Results from the Total Occlusion Study of Canada (TOSCA)

American Heart Journal

Volumn 142, Issue 5, 2001, Pages 776-781

  Berger, Peter B ^a   Dzavik, Vladimir ^b   Penn, Ian M ^c   Catellier, Diane ^d   Buller, Christopher E ^c  

^a MAYO CLINIC   (United States)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c VANCOUVER GENERAL HOSPITAL   (Canada)

^d IL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; TICLOPIDINE;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CANADA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; CORONARY STENT; DRUG EFFICACY; FEMALE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0034751366     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhj.2001.118743     Document Type: Article

References (25)

1. Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty
2. Antiplatelet agents are effective in reducing the immediate complications of PTCA: Results from ticlopidine multicenter trial
3. Results of a randomized trial of ticlopidine versus placebo for prevention of acute closure and restenosis after coronary angioplasty (PTCA): The Tact study
4. Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade: Evaluation of platelet IIb/IIIa inhibitor for stenting
5. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty
6. Platelet glycoprotein IIb/IIIa blockade and low-dose heparin during percutaneous coronary revascularization
7. Randomized placebo-controlled trial of abciximab before and during intervention in refractory unstable angina: The Capture study
8. A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting: Stent Anticoagulation Restenosis Study Investigators
9. A randomized comparison of combined ticlopidine and aspirin therapy versus aspirin therapy alone after successful intravascular ultrasound-guided stent implantation
10. Primary stenting versus balloon angioplasty in occluded coronary arteries: The Total Occlusion Study of Canada (TOSCA)
11. An open design, multicentre, randomized trial of percutaneous transluminal coronary angioplasty versus stenting, with a heparin-coated stent, of totally occluded coronary arteries: Rationale, trial design and baseline patient characteristics
12. Clopidogrel inhibits the binding of ADP analogues to the receptor mediating inhibition of platelet adenylate cyclase
13. Clopidogrel
14. ADP receptors on platelets and ADP-selective antiaggregating agents
15. Risk factors, time course and treatment effect for restenosis after successful percutaneous transluminal coronary angioplasty of chronic total occlusion
16. Initial and long-term outcome of 354 patients after coronary balloon angioplasty of total coronary artery occlusions
17. Procedural outcome of angioplasty for total coronary artery occlusion: An analysis of 971 lesions in 905 patients
18. Percutaneous transluminal coronary angioplasty of chronic total occlusions: Primary success, restenosis, and long-term clinical follow-up
19. Elective PTCA of totally occluded coronary arteries not associated with acute myocardial infarction: Short-term and long-term results
20. Angioplasty in total coronary artery occlusion: Experience in 76 consecutive patients
21. Transluminal angioplasty of occluded coronary arteries: Use of a movable guide wire system
22. Early and late outcome of percutaneous transluminal coronary agioplasty for subacute and chronic total coronary occlusion
23. Outcome and complications of 500 consecutive chronic total occlusion angioplasties
24. Recoil, dissection, and reocclusion early following PTCA of total coronary occlusions
25. Silent early reocclusion after successful coronary angioplasty of chronic total occlusions